MIGLINO, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 1.979
Totale 1.979
Nazione #
IT - Italia 1.979
Totale 1.979
Città #
Genova 1.015
Rapallo 474
Genoa 452
Bordighera 38
Totale 1.979
Nome #
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas, file e268c4ca-bf91-a6b7-e053-3a05fe0adea1 765
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia, file e268c4ca-ba16-a6b7-e053-3a05fe0adea1 242
Prompt detection of L-asparaginase inactivation is crucial to optimize treatment efficacy also in aggressive lymphomas, file e268c4ca-b787-a6b7-e053-3a05fe0adea1 162
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients, file e268c4ca-ca7c-a6b7-e053-3a05fe0adea1 136
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma, file e268c4ca-ba0d-a6b7-e053-3a05fe0adea1 121
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs, file e268c4cb-4326-a6b7-e053-3a05fe0adea1 95
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis, file e268c4ca-f531-a6b7-e053-3a05fe0adea1 89
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline, file e268c4ca-5a7e-a6b7-e053-3a05fe0adea1 82
Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach, file e268c4ca-eb89-a6b7-e053-3a05fe0adea1 72
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis, file e268c4cb-d056-a6b7-e053-3a05fe0adea1 65
Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: A Possible Role for RANK/RANKL Pathway, file e268c4cd-4366-a6b7-e053-3a05fe0adea1 53
Epigenetic Regulation in Myelodysplastic Syndrome as A Consequence of A MicroRNA Dysregulation, file e268c4ce-6d77-a6b7-e053-3a05fe0adea1 12
Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression., file e268c4c6-cdf3-a6b7-e053-3a05fe0adea1 8
Impact of hematological malignancies in patients undergoing cardiac surgery, file e268c4c9-b7c2-a6b7-e053-3a05fe0adea1 7
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells vulnerability to DNA-damaging agents, file e268c4ca-8944-a6b7-e053-3a05fe0adea1 7
Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines, file e268c4cd-10d5-a6b7-e053-3a05fe0adea1 7
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information, file e268c4ca-235e-a6b7-e053-3a05fe0adea1 6
Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia., file e268c4c6-d183-a6b7-e053-3a05fe0adea1 5
Chronic graft versus host disease as a weapon for treating chronic myelomonocytic leukemia, file e268c4cb-7f78-a6b7-e053-3a05fe0adea1 5
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission., file e268c4c6-8c89-a6b7-e053-3a05fe0adea1 4
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning., file e268c4c6-d182-a6b7-e053-3a05fe0adea1 4
Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation, file e268c4cb-7f79-a6b7-e053-3a05fe0adea1 4
Early chemotherapy intensification with escalated beacopp in patients with advanced-stage hodgkin lymphoma with a positive interim positron emission tomography/computed tomography scan after two abvd cycles: Long-term results of the GITIL/FIL HD 0607 trial, file e268c4cb-9c68-a6b7-e053-3a05fe0adea1 4
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file e268c4ce-349a-a6b7-e053-3a05fe0adea1 4
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells, file 90274659-2248-4db2-a2d9-8e3628c61b91 3
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation, file e268c4ca-94f7-a6b7-e053-3a05fe0adea1 3
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas., file e268c4c6-14d6-a6b7-e053-3a05fe0adea1 2
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives, file e268c4ca-93e7-a6b7-e053-3a05fe0adea1 2
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes, file e268c4ca-a203-a6b7-e053-3a05fe0adea1 2
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatment, file e268c4ce-5ee8-a6b7-e053-3a05fe0adea1 2
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis, file 6e450a3b-3515-4668-b89d-219850687514 1
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromes, file e268c4ca-d2c5-a6b7-e053-3a05fe0adea1 1
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia, file e268c4ca-fd4d-a6b7-e053-3a05fe0adea1 1
Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report, file e268c4cb-9a98-a6b7-e053-3a05fe0adea1 1
Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department, file e268c4cc-1236-a6b7-e053-3a05fe0adea1 1
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status, file e268c4cd-6ab8-a6b7-e053-3a05fe0adea1 1
Totale 1.979
Categoria #
all - tutte 3.994
article - articoli 3.927
book - libri 0
conference - conferenze 7
curatela - curatele 0
other - altro 60
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.988


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 1 1
2019/2020122 10 0 0 3 3 7 17 16 32 16 12 6
2020/2021281 7 16 15 17 9 29 16 33 29 35 26 49
2021/2022634 46 32 28 101 77 34 20 37 58 32 119 50
2022/2023579 26 41 105 49 41 87 32 28 41 40 54 35
2023/2024361 27 31 35 25 48 19 74 56 24 22 0 0
Totale 1.979